
Associated Press - November 21, 2003
"There are 6 million people in the world who need medication for HIV AIDS, of whom only about 300,000 are getting anti-retroviral drugs," Clinton told a news conference at Ranbaxy Laboratories (500359.BY), in this city on the outskirts of New Delhi, India's capital.
His William J. Clinton Foundation has brokered an agreement for four Indian drug companies and a South African firm to cut the price of their AIDS drugs for distribution in South Africa, Mozambique, Rwanda, Tanzania, Bahamas.
He said the initiative will make HIV drugs available at a cost of $139 a year.
"It cuts costs of HIV/AIDS drugs by two-thirds, making it affordable for a maximum number of people, considering the staggering dimension of this problem," he said.
He said without treatment being available, young people cannot be made to come and get tested.
Ira Magaziner, head of the Clinton foundation's HIV/AIDS initiative, told reporters the agreement will make HIV/AIDS drugs affordable and accessible to 2 million people in Africa and the Caribbean.
Four Indian drug companies, Ranbaxy Laboratories, Matrix Laboratories (524794.BY), Cipla (500087.BY) and Hetero Drugs, along with Aspen Pharmacare (APN.JO) of South Africa have agreed to supply countries with low-cost drugs under the arrangement with the Clinton Foundation.
Clinton said Friday that the Indian companies are in a position to give high quality drugs and "the companies have agreed to go in for lower profit on each dose and to look for higher volumes by tying up with the Clinton Foundation's AIDS initiative."
Although nearly 70% of HIV/AIDS cases are in Africa, it is also surfacing in other parts of the world, Clinton said, mentioning rural China and the countries of the former Soviet Union.
Later Friday, Clinton met with Prime Minister Atal Bihari Vajpayee, on his third visit to India. He came first, as president, in 2000, warming up Indo-U.S. ties that had been chilly since the Cold War. He visited again in 2001 to encourage programs empowering women and providing rehabilitation after India's devastating Jan. 26, 2001 earthquake.
031121
AP031138
Copyright © 2003 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .